+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC), By Cultivation (Indoor Cultivation, Outdoor Cultivation) By End-use (Medical Use, Recreational Use), And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • March 2025
  • Region: United States
  • Grand View Research
  • ID: 6062595
The U.S. cannabis market size is expected to reach USD 76.39 billion by 2030, registering a CAGR of 11.5% from 2025 to 2030. Factors such as legalization of medicinal cannabis, growing consumer disposable income, rising demand for cannabis from the pharmaceutical industry, growing consumer awareness of the health benefits of cannabis, presence of major manufacturers, and the approval of the U.S. farm bill are expected to boost the market growth.

Cannabis is generally used for the treatment of various conditions, such as cancer, mental disorders, pain management, & nausea, and for recreational purposes. The high prevalence of cancer is expected to be one of the factors driving the adoption of medical marijuana over the forecast period. For instance, according to an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were anticipated to occur in the U.S. In addition to that, two cannabidiol (CBD) drugs namely nabilone and dronabinol are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy in the U.S.

Rising awareness among people regarding the therapeutic benefits of cannabis and the launch of cannabis certification programs through partnerships drives market growth. For instance, in December 2023, Bellarmine University introduced a cannabis education certificate program offered by a public Kentucky University focusing on agriculture, business, medicine, and law in the fast-changing cannabis industry.

With the legalization of cannabis in different areas of the U.S. for medical & recreational use, many well-known personalities and mainstream companies are seeking to benefit from this trend. For instance, celebrities such as Jay-Z and Snoop Dogg have joined this movement by launching branded cannabis products (Monogram). However, avid cannabis consumers seek information regarding the extent of the celebrity’s involvement in the cultivation process. Despite this scrutiny, more celebrities are expected to follow this trend and enter the cannabis cultivation industry.

New technologies and improvements are continually being developed for the cultivation of cannabis. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated to assist cultivators in optimizing their resources, which further drives the market growth.

U.S. Cannabis Market Report Highlights

  • The marijuana segment dominated the market with the highest revenue share of 87.7% in 2024 and is expected to grow at the fastest CAGR over the forecast period. The hemp segment is anticipated to grow at a significant CAGR from 2025 to 2030.
  • The CBD segment dominated the market with the largest revenue share of 63.3% in 2024. CBD is the non-psychoactive compound found in the cannabis plant, and its adoption is increasing for a wide range of health issues.
  • The indoor cultivation segment dominated the market with the largest revenue share of 54.8% in 2024 and is expected to grow at the fastest CAGR over the forecast period. The outdoor cultivation segment held a significant share in 2024.
  • The recreational use segment dominated the market with a revenue share of 66.9% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. The medical use segment is anticipated to grow significantly over the forecast period.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This Report Addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. Cultivation outlook
2.2.4. End Use outlook
2.3. Competitive Insights
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. U.S. Cannabis Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis Tools: U.S. Cannabis Market
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Current Market Trends in Cannabis Industry
3.5. Regulatory Scenario
3.6. Licensing Scenario in the U.S.
3.7. Cannabis Consumption Pattern Analysis
3.8. Legal Cannabis Potential Trade Opportunity
3.9. Legal Cannabis Seed to Shelf Story
3.10. Supply Chain Analysis
3.11. Legal Cannabis Industry: U.S. Country Case Studies
3.12. Guidelines and Requirements for Cannabis Cultivation
3.13. Cannabis Facility Design and Equipment Requirements
3.14. Government Policy Designing Cannabis Guidelines
3.14.1. Federal Cannabis Policy
3.14.2. Policy Challenges and Opportunities
3.15. Reimbursement Policies in the U.S
3.16. Taxation Policies in The U.S.
Chapter 4. U.S. Cannabis Market: Source Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Source Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. U.S. Cannabis Market, by Source, 2018 to 2030
4.5. Marijuana
4.5.1. Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Flower Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2.1. Flower Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Oil and Tinctures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3.1. Oil and Tinctures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Hemp
4.6.1. Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Hemp Oil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2.1. Hemp Oil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Industrial Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3.1. Industrial Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Cannabis Market: Derivative Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Derivative Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. U.S. Cannabis Market, by Derivative, 2018 to 2030
5.5. CBD
5.5.1. CBD Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. THC
5.6.1. THC Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Cannabis Market: Cultivation Estimates & Trend Analysis
6.1. Definition and Scope
6.2. Cultivation Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. U.S. Cannabis Market, by Cultivation, 2018 to 2030
6.5. Indoor Cultivation
6.5.1. Indoor Cultivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Greenhouse Cultivation
6.6.1. Greenhouse Cultivation Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Outdoor Cultivation
6.7.1. Outdoor Cultivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Cannabis Market: End Use Estimates & Trend Analysis
7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2024 & 2030
7.3. Segment Dashboard
7.4. U.S. Cannabis Market, by End Use, 2018 to 2030
7.5. Medical Use
7.5.1. Medical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Cancer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2.1. Cancer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Chronic Pain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3.1. Chronic Pain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Depression and Anxiety Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4.1. Depression and Anxiety Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Arthritis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5.1. Arthritis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6.1. Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Glaucoma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7.1. Glaucoma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Migraines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8.1. Migraines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Multiple Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10.1. Multiple Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. AIDS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11.1. AIDS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12.1. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Alzheimers's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13.1. Alzheimers's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.15. Parkinson's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.15.1. Parkinson's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.16. Tourettes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.16.1. Tourettes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.17. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.17.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Recreational Use
7.6.1. Recreational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Industrial Use
7.7.1. Industrial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. U.S. Cannabis Market: Competitive Landscape
8.1. Participant’s Categorization
8.2. Company Market Position Analysis, 2024
8.3. Strategy Mapping
8.4. Company Profiles
8.4.1. Charlotte's Web, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Medical Marijuana, Inc.
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Canopy Growth Corporation
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. NuLeaf Naturals, LLC
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. CV Sciences, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. The Cronos Group
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Organigram Holding, Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Irwin Naturals
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Tilray Brands
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Aurora Cannabis Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 U.S. cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 U.S. cannabis market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. cannabis market, by cultivation, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market research approaches
Fig. 7 Market formulation & validation
Fig. 8 U.S. cannabis market: market outlook
Fig. 9 U.S. cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Industry value chain analysis
Fig. 13 U.S. cannabis market driver impact
Fig. 14 U.S. cannabis market restraint impact
Fig. 15 U.S. cannabis market strategic initiatives analysis
Fig. 16 U.S. cannabis market: Source movement analysis
Fig. 17 U.S. cannabis market: Source outlook and key takeaways
Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
Fig. 22 Flower market estimates and forecasts, 2018 - 2030
Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
Fig. 24 U.S. cannabis market: Derivatives movement analysis
Fig. 25 U.S. cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2018 - 2030
Fig. 27 THC market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 U.S. cannabis market: Cultivation movement analysis
Fig. 30 U.S. cannabis market: Cultivation outlook and key takeaways
Fig. 31 Indoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 32 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
Fig. 33 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 34 U.S. cannabis market: End-use movement analysis
Fig. 35 U.S. cannabis market: End-use outlook and key takeaways
Fig. 36 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 37 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 38 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 39 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 40 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 41 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 42 Cancer market estimates and forecasts, 2018 - 2030
Fig. 43 Migraines market estimates and forecasts, 2018 - 2030
Fig. 44 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 45 Alzheimer’s market estimates and forecasts, 2018 - 2030
Fig. 46 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 47 AIDS market estimates and forecasts, 2018 - 2030
Fig. 48 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 49 Tourette’s market estimates and forecasts, 2018 - 2030
Fig. 50 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 51 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 52 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 53 Others market estimates and forecasts, 2018 - 2030
Fig. 54 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 55 Key company categorization
Fig. 56 Heatmap Analysis, 2024

Companies Mentioned

  • Medical Marijuana, Inc.
  • NuLeaf Naturals, LLC
  • CV Sciences, Inc.
  • CHARLOTTE’S WEB.
  • The Cronos Group
  • Organigram Holding, Inc
  • Irwin Naturals
  • Tilray Brands
  • Canopy Growth Corporation
  • Aurora Cannabis

Methodology

Loading
LOADING...

Table Information